Strategies of reducing input sample volume for extracting circulating cell-free nuclear DNA and mitochondrial DNA in plasma

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Chemistry and Laboratory Medicine

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1515/cclm.2011.773PMID 22040238
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantification of Circulating Cell-Free DNA in the Serum of Patients with Obstructive Sleep Apnea–Hypopnea Syndrome

  2010cited by this paper
• Decoding circulating nucleic acids in human serum using microfluidic single molecule spectroscopy.

  2010cited by this paper
• Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.

  2010cited by this paper
• DNA extraction procedures meaningfully influence qPCR-based mtDNA copy number determination.

  2009cited by this paper
• Simultaneous quantitative assessment of circulating cell-free mitochondrial and nuclear DNA by multiplex real-time PCR

  2009cited by this paper
• [Haemodynamic role of blood-plasma circulating cell-free DNA and contained therein high-molecular-weight CpG-rich fraction in pathogenesis of arterial hypertension and atherosclerosis obliterans of carotid arteries].

  2009cited by this paper
• Evaluation of fluorescence-based methods for total vs. amplifiable DNA quantification in plasma of lung cancer patients.

  2008cited by this paper
• Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer.

  2008cited by this paper
• Quantification of Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer

  2008cited by this paper
• Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis.

  2007cited by this paper
• Circulating (cell‐free) nucleic acids – A promising, non‐invasive tool for early detection of several human diseases

  2007cited by this paper
• Circulating tumour‐associated plasma DNA represents an independent and informative predictor of prostate cancer

  2006cited by this paper
• Is the quantity of circulatory cell-free DNA in human plasma and serum samples associated with gender, age and frequency of blood donations?

  2006cited by this paper
• Plasma mitochondrial DNA concentrations after trauma.

  2004cited by this paper
• Preferential isolation of fragmented DNA enhances the detection of circulating mutated k-ras DNA.

  2004cited by this paper
• Role of Cell‐Free Plasma DNA as a Diagnostic Marker for Prostate Cancer

  2004cited by this paper
• Quantification of free circulating DNA as a diagnostic marker in lung cancer.

  2003cited by this paper
• Differential bone marrow aspirate DNA yields from commercial extraction kits

  2002cited by this paper
• Approximately half of the erythroblasts in maternal blood are of fetal origin.

  1999cited by this paper
• Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients.

  1998cited by this paper
• Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.

  1998cited by this paper
• An inexpensive and simple method for DNA purifications on silica particles.

  1993cited by this paper

• Pre-analytical optimization of cell-free DNA and extracellular vesicle-derived DNA for mutation detection in liquid biopsies.

  2026cites this paper
• Early detection of liver injuries by the Serum enhanced binding test sensitive to albumin post-transcriptional modifications

  2024cites this paper
• Levels of Circulating DNA in Blood Serum and DNA Damage in Leukocytes of Healthy Donors of Different Genders and Ages

  2021cites this paper
• CELL-FREE DNA: BIOSPECIMEN COLLECTION AND PROCESSING

  2020cites this paper
• Plasma C-MYC level manifesting as an indicator in progression of breast cancer.

  2019cites this paper
• Effects of Pre-analytical Variables on Cell-free DNA Extraction for Liquid Biopsy

  2019cites this paper
• Cell-free DNA as a biomarker in stroke: Current status, problems and perspectives

  2018cites this paper
• rognostic role of APC and RASSF 1 A promoter methylation status in ell free circulating DNA of operable gastric cancer patients

  2015cites this paper
• Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.

  2015cites this paper
• Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies

  2014cites this paper
• Salinomycin as a potential chemotherapeutic compound in cisplatin-resistant ovarian cancer : effects and mechanisms

  2013cites this paper
• Biomarkers in the treatment of cancer: opportunities and pitfalls

  2013cites this paper
• Preanalytical quality improvement: in quality we trust

  2013cites this paper
• Circulating cell-free mitochondrial DNA as a novel cancer biomarker: opportunities and challenges

  2012cites this paper